A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data

Table 1 Costs and CRT device runtime

Input parameter	Mean	SD	PSA distribution
Costs in €
Implantation CRT-P	11,092.44	2807.39	Gamma
Implantation CRT-D	16,648.03	2857.33	Gamma
Replacement CRT-P	5643.52	1209.20	Gamma
Replacement CRT-D	8095.18	1123.75	Gamma
Heart failure hospitalisation	4077.23	2611.73	Gamma
Quarterly outpatient costs	49.25	47.98	Gamma
Monthly medication costs	180.82	205.54	Gamma
Future medical costs unrelated to HF (65–84 years)	7275	–	–
Future medical costs unrelated to HF (older 85 years)	16,616	–	–
Device longevity in months
CRT-P	98*	–	Poisson
CRT-D	72*	–	Poisson

CRT-P: cardiac biventricular pacemaker, CRT-D: cardiac biventricular defibrillator, HF: heart failure, SD: standard deviation, PSA: probabilistic sensitivity analysis
*Median

ISSN: 1478-7547